Democrats Prepare for Next Attempt to Lower Prescription Drug Prices
On the heels of Democrats’ recent failure to pass the Build Back Better bill, Senate Majority Leader Chuck Schumer (D-N.Y.) [...]
Congress Pursuing Price Setting Measures that May Not Benefit Patients
In a new PhRMA article, Nicole Longo argues that Congress is starting off the year on a wrong foot with [...]
Forbes: 2022 Economy, Politics, and Drug Pricing Legislation Predictions
In a Forbes piece published early this month, Joshua Cohen makes predictions about the economy, politics, and drug pricing reform [...]
Possible Impact of the Build Back Better Plan on Chronic Illness – Patients Rising Podcast
With the Build Back Better Act having passed the House, some question how changes to the bill in the Senate [...]
Advertisement
